Literature DB >> 2389576

Clozapine--a new and different neuroleptic.

E Haller1, R L Binder.   

Abstract

These discussions are selected from the weekly staff conferences in the Department of Medicine, University of California, San Francisco. Taken from a transcription, it has been edited by Homer A. Boushey, MD, Professor of Medicine, and Nathan M. Bass, MD, PhD, Associate Professor of Medicine, under the direction of Lloyd H. Smith, Jr, MD, Professor of Medicine and Associate Dean in the School of Medicine.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2389576      PMCID: PMC1002468     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  17 in total

1.  Clozapine--a potential antipsychotic agent without extrapyramidal manifestations.

Authors:  R Matz; W Rick; H Thompson; S Gershon
Journal:  Curr Ther Res Clin Exp       Date:  1974-07

2.  Effect of clozapine on the turnover of dopamine in the corpus striatum and in the limbic system.

Authors:  N E Andén; G Stock
Journal:  J Pharm Pharmacol       Date:  1973-04       Impact factor: 3.765

3.  Clozapine and haloperidol in a single-blind cross-over trial: therapeutic and biochemical aspects in the treatment of schizophrenia.

Authors:  J Gerlach; P Koppelhus; E Helweg; A Monrad
Journal:  Acta Psychiatr Scand       Date:  1974       Impact factor: 6.392

4.  Letter: Clozapine and agranulocytosis.

Authors:  R W Griffith; K Saameli
Journal:  Lancet       Date:  1975-10-04       Impact factor: 79.321

5.  The risks and benefits of clozapine versus chlorpromazine.

Authors:  J Claghorn; G Honigfeld; F S Abuzzahab; R Wang; R Steinbook; V Tuason; G Klerman
Journal:  J Clin Psychopharmacol       Date:  1987-12       Impact factor: 3.153

6.  Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.

Authors:  J Kane; G Honigfeld; J Singer; H Meltzer
Journal:  Arch Gen Psychiatry       Date:  1988-09

7.  Clozapine, chlorpromazine, and placebo in newly hospitalized, acutely schizophrenic patients: a controlled, double-blind comparison.

Authors:  B Shopsin; H Klein; M Aaronsom; M Collora
Journal:  Arch Gen Psychiatry       Date:  1979-06

8.  Treatment outcome with clozapine in tardive dyskinesia, neuroleptic sensitivity, and treatment-resistant psychosis.

Authors:  J G Small; V Milstein; J D Marhenke; D D Hall; J J Kellams
Journal:  J Clin Psychiatry       Date:  1987-07       Impact factor: 4.384

9.  Important issues in the drug treatment of schizophrenia.

Authors:  J M Davis; C B Schaffer; G A Killian; C Kinard; C Chan
Journal:  Schizophr Bull       Date:  1980       Impact factor: 9.306

10.  Effect of clozapine on human serum prolactin levels.

Authors:  H Y Meltzer; D J Goode; P M Schyve; M Young; V S Fang
Journal:  Am J Psychiatry       Date:  1979-12       Impact factor: 18.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.